Crosscheck

Your medical. Crosschecked.

Migraine

Frovatriptan

Longer-acting triptan, migraine rescue
Other names: Frova

FAA guidance

Acceptable with conditions.

Wait

48 hours

after each dose in the FAA's migraine medication sheet and the FAA's CACI – Migraine and Chronic Headache Worksheet

Different waits apply in other cases.

Examiner

CACI: the examiner can issue when the condition's worksheet criteria are met. Applicants for first- or second-class must provide the worksheet's information annually; applicants for third-class with each required exam

FAA label

CACI ACCEPTABLE

Source: FAA, Migraine Medication. FAA date 26 August 2026. Checked by Crosscheck 14 October 2026

The FAA's migraine medication sheet lists frovatriptan as CACI-acceptable migraine rescue medication with a 48-hour post-dose observation, among the triptans with a longer half-life, acceptable when used occasionally and unacceptable for daily use, and the FAA's CACI – Migraine and Chronic Headache Worksheet gives it 48 hours.

Track your medications
Compare FAA documents: frovatriptanWhat each of the three FAA documents says, in plain wordsOpen

Wait

  • 72 hours in the older copy of that worksheet (updated 08/27/2025
  • the standalone worksheet is updated 08/26/2026) printed in the FAA's Migraine and Chronic Headache disposition table

The copy of that worksheet printed in the FAA's Migraine and Chronic Headache disposition table gives it 72 hours. The documents do not say the same thing; all three are quoted.

FAA rule for migraine medication: The FAA says migraine relief or rescue medication is acceptable when used occasionally and unacceptable for daily use, and that its post-dose observation time (no-fly warning) is based on the drug's half-life. It says that if several relief medications are needed on a recurring basis to stop symptoms, this is considered a complicated migraine, and the examiner should defer. For relief or rescue medication the worksheet lists, the FAA's CACI – Migraine and Chronic Headache Worksheet says the examiner can issue if the pilot meets all of its acceptable certification criteria, which include no more than one episode per month, no more than 2 outpatient clinic or urgent care visits for symptom exacerbation in the last 12 months (even if symptoms fully resolved), and no history of in-patient hospitalizations for headaches; it says narcotics, Fiorinal, Fioricet and Midrin are not acceptable for relief or rescue. FAA, Migraine Medication

Show the FAA's words: frovatriptanThe official FAA wording: three passages, each with its document and dateOpen
FAA, Migraine Medication · FAA date 26 August 2026
Post-dose observation time (no fly warning) is based on medication half-life. ACCEPTABLE when used occasionally. Unacceptable for daily use.
CACI ACCEPTABLE - Migraine Relief/Rescue Medication
Serotonin 5HT1 receptor agonist (longer half-life) [Triptan]: eletriptan (Relpax), frovatriptan (Frova), 48 hours
FAA, CACI – Migraine and Chronic Headache Worksheet · FAA date 26 August 2026
Medications or treatment - Relief/Rescue
One or more of the following:
Triptans (monotherapy or with NSAID combination) 24 hour no-fly Except eletriptan (Relpax) and frovatriptan (Frova): 48 hours
FAA, Migraine and Chronic Headache · FAA date 24 September 2025
Medications or treatment - Abortive
One or more of the following:
Triptans (monotherapy or with NSAID combination) 24 hour no-fly Except eletriptan (Relpax) and frovatriptan (Frova): 72 hours
Sources and dates: frovatriptanThree FAA documents, with the FAA's date and when Crosscheck checked themOpen

See also

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.